Carcinoma, Pancreatic Ductal - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	Carcinoma, Pancreatic Ductal	go back to main search page
Accession:	RDO:0007458	browse the term
Definition:	Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
Synonyms:	exact_synonym:	Duct Cell Carcinoma of the Pancreas; Ductal Carcinoma of the Pancreas; Pancreas Duct-Cell Carcinoma; Pancreas Duct-Cell Carcinomas; Pancreatic Duct Cell Carcinoma; Pancreatic Ductal Carcinomas
	primary_id:	MESH:D021441

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

Carcinoma, Pancreatic Ductal
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ace	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1			ISS	11	105,829,261	105,851,259	RGD:2325211	RGD
G	Ace2	angiotensin I converting enzyme (peptidyl-dipeptidase A) 2			ISS	X	160,577,274	160,626,350	RGD:2325210	RGD
G	Adam8	a disintegrin and metallopeptidase domain 8		Disease_progression	ISS	7	147,164,840	147,178,387	RGD:2325243	RGD
G	Adam9	a disintegrin and metallopeptidase domain 9 (meltrin gamma)		Disease_progression	ISS	8	26,060,083	26,127,394	RGD:2325249	RGD
G	Agr2	anterior gradient 2 (Xenopus laevis)			ISS	12	36,719,512	36,730,668	RGD:2325659	RGD
G	Alb	albumin		Disease_progression	ISS	5	90,889,915	90,905,629	RGD:2325677	RGD
G	Anxa2	annexin A2			ISS	9	69,301,490	69,339,592	RGD:2325731	RGD
G	Anxa2	annexin A2		Disease_progression	ISS	9	69,301,490	69,339,592	RGD:2317307	RGD
G	Anxa5	annexin A5			ISS	3	36,347,845	36,374,809	RGD:2317538	RGD
G	Anxa8	annexin A8			ISS	14	34,899,176	34,913,757	RGD:2325735	RGD
G	Apoc1	apolipoprotein C-I			ISS	7	20,274,830	20,278,007	RGD:2325793	RGD
G	Calr	calreticulin			ISS	8	87,365,987	87,370,830	RGD:2326165	RGD
G	Cckar	cholecystokinin A receptor			ISS	5	54,089,724	54,098,943	RGD:4110818	RGD
G	Cckar	cholecystokinin A receptor			ISS	5	54,089,724	54,098,943	RGD:4110816	RGD
G	Cckbr	cholecystokinin B receptor			ISS	7	112,574,334	112,584,852	RGD:4110816	RGD
G	Cd40	CD40 antigen			IED	2	164,881,136	164,897,154	RGD:5490301	RGD
G	Cd40	CD40 antigen			ISS	2	164,881,136	164,897,154	RGD:5490524	RGD
G	Cldn4	claudin 4			ISS	5	135,420,993	135,422,804	RGD:2317592	RGD
G	Egf	epidermal growth factor		Disease_progression	ISS	3	129,380,493	129,458,240	RGD:2317644	RGD
G	Fasl	Fas ligand (TNF superfamily, member 6)			ISS	1	163,710,820	163,718,626	RGD:2317747	RGD
G	Fasl	Fas ligand (TNF superfamily, member 6)			ISS	1	163,710,820	163,718,626	RGD:2317741	RGD
G	Fgf2	fibroblast growth factor 2			ISS	3	37,247,575	37,303,752	RGD:2317756	RGD
G	Fgf2	fibroblast growth factor 2		Disease_progression	ISS	3	37,247,575	37,303,752	RGD:2317758	RGD
G	Fscn1	fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus)		Disease_progression	ISS	5	143,722,034	143,734,868	RGD:2317790	RGD
G	Gstp1	glutathione S-transferase, pi 1		Resistance	ISS	19	4,035,411	4,037,912	RGD:2317806	RGD
G	Gstp1	glutathione S-transferase, pi 1			ISS	19	4,035,411	4,037,912	RGD:2317809	RGD
G	Gstp1	glutathione S-transferase, pi 1			ISS	19	4,035,411	4,037,912	RGD:2317811	RGD
G	Igf1	insulin-like growth factor 1			IED	10	87,321,801	87,399,792	RGD:2317639	RGD
G	Igf1r	insulin-like growth factor I receptor			ISS	7	75,097,143	75,378,553	RGD:2317652	RGD
G	Igf1r	insulin-like growth factor I receptor			ISS	7	75,097,143	75,378,553	RGD:2317649	RGD
G	Il4	interleukin 4			ISS	11	53,425,962	53,432,167	RGD:2317264	RGD
G	Il4ra	interleukin 4 receptor, alpha			ISS	7	132,695,796	132,722,988	RGD:2317264	RGD
G	Ins2	insulin II			ISS	7	149,864,561	149,865,613	RGD:2317248	RGD
G	Krt7	keratin 7		Disease_progression	ISS	15	101,242,834	101,258,237	RGD:2317307	RGD
G	L1cam	L1 cell adhesion molecule		Severity	ISS	X	71,099,119	71,126,173	RGD:6483447	RGD
G	Mcm7	minichromosome maintenance deficient 7 (S. cerevisiae)			ISS	5	138,605,817	138,613,090	RGD:2317697	RGD
G	Mdm2	transformed mouse 3T3 cell double minute 2		Severity	ISS	10	117,125,961	117,147,772	RGD:2317416	RGD
G	Mdm2	transformed mouse 3T3 cell double minute 2		Onset	ISS	10	117,125,961	117,147,772	RGD:2317414	RGD
G	Men1	multiple endocrine neoplasia 1			ISS	19	6,334,979	6,340,894	RGD:2317294	RGD
G	Met	met proto-oncogene			ISS	6	17,413,957	17,523,980	RGD:2317530	RGD
G	Mgmt	O-6-methylguanine-DNA methyltransferase			ISS	7	144,086,294	144,319,871	RGD:2317664	RGD
G	Mgmt	O-6-methylguanine-DNA methyltransferase		Susceptibility	ISS	7	144,086,294	144,319,871	RGD:2317648	RGD
G	Mmp2	matrix metallopeptidase 2		Severity	ISS	8	95,351,227	95,377,319	RGD:2325746	RGD
G	Mmp9	matrix metallopeptidase 9			ISS	2	164,773,751	164,781,346	RGD:2325844	RGD
G	Mmp9	matrix metallopeptidase 9			ISS	2	164,773,751	164,781,346	RGD:2325830	RGD
G	Msln	mesothelin		Disease_progression	ISS	17	25,885,558	25,891,272	RGD:2326055	RGD
G	Msln	mesothelin			ISS	17	25,885,558	25,891,272	RGD:2326065	RGD
G	Muc1	mucin 1, transmembrane		Disease_progression	ISS	3	89,032,974	89,037,291	RGD:2324633	RGD
G	Muc1	mucin 1, transmembrane			ISS	3	89,032,974	89,037,291	RGD:2317983	RGD
G	Muc1	mucin 1, transmembrane		Disease_progression	ISS	3	89,032,974	89,037,291	RGD:2324616	RGD
G	Muc4	mucin 4			ISS	16	32,735,972	32,782,477	RGD:2324946	RGD
G	Muc4	mucin 4		Disease_progression	ISS	16	32,735,972	32,782,477	RGD:2324942	RGD
G	Muc5ac	mucin 5, subtypes A and C, tracheobronchial/gastric			ISS	7	148,974,916	149,005,040	RGD:2324986	RGD
G	Muc5ac	mucin 5, subtypes A and C, tracheobronchial/gastric		Disease_progression	ISS	7	148,974,916	149,005,040	RGD:2324907	RGD
G	Muc5b	mucin 5, subtype B, tracheobronchial			ISS	7	149,024,977	149,058,990	RGD:2324986	RGD
G	Nme1	NME/NM23 nucleoside diphosphate kinase 1			ISS	11	93,820,239	93,829,835	RGD:5132867	RGD
G	Nos2	nitric oxide synthase 2, inducible			IPM	11	78,734,361	78,773,626	RGD:2325254	RGD
G	Notch1	notch 1			IPM	2	26,313,422	26,359,342	RGD:2325323	RGD
G	Notch1	notch 1			IPM	2	26,313,422	26,359,342	RGD:2325324	RGD
G	Ntrk3	neurotrophic tyrosine kinase, receptor, type 3		Disease_progression	ISS	7	85,337,000	85,722,724	RGD:2325660	RGD
G	Ntrk3	neurotrophic tyrosine kinase, receptor, type 3			ISS	7	85,337,000	85,722,724	RGD:2325663	RGD
G	Palld	palladin, cytoskeletal associated protein			ISS	8	63,993,818	64,381,487	RGD:2325781	RGD
G	Pms1	postmeiotic segregation increased 1 (S. cerevisiae)			ISS	1	53,246,031	53,353,840	RGD:2324870	RGD
G	Pparg	peroxisome proliferator activated receptor gamma		Disease_progression	ISS	6	115,311,239	115,440,419	RGD:2317461	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			IPM	1	151,947,254	151,955,147	RGD:2317185	RGD
G	Rxra	retinoid X receptor alpha		Severity	ISS	2	27,532,721	27,618,839	RGD:2317461	RGD
G	Serpina1e	serine (or cysteine) peptidase inhibitor, clade A, member 1E			ISS	12	105,185,141	105,195,107	RGD:2317811	RGD
G	Slc2a2	solute carrier family 2 (facilitated glucose transporter), member 2			IEP	3	28,596,825	28,627,283	RGD:2324975	RGD
G	Smo	smoothened homolog (Drosophila)			ISS	6	29,685,497	29,711,366	RGD:2324981	RGD
G	Tgfb1	transforming growth factor, beta 1		Disease_progression	ISS	7	26,472,021	26,490,015	RGD:2325019	RGD
G	Tgfbr2	transforming growth factor, beta receptor II		Disease_progression	ISS	9	115,996,813	116,084,481	RGD:2317500	RGD
G	Tgfbr2	transforming growth factor, beta receptor II			IPM	9	115,996,813	116,084,481	RGD:2317498	RGD
G	Thbs1	thrombospondin 1			ISS	2	117,937,658	117,952,869	RGD:2325022	RGD
G	Thbs1	thrombospondin 1		Disease_progression	ISS	2	117,937,658	117,952,869	RGD:2325025	RGD
G	Tmprss3	transmembrane protease, serine 3			ISS	17	31,316,210	31,335,919	RGD:2325152	RGD
G	Tymp	thymidine phosphorylase		Disease_progression	ISS	15	89,202,362	89,207,467	RGD:2325155	RGD
G	Vhl	von Hippel-Lindau tumor suppressor			ISS	6	113,574,015	113,581,627	RGD:2325022	RGD

Term paths to the root

Path 1
Term	Annotations
Diseases	25889
Digestive System Diseases	2037
Pancreatic Diseases	582
Pancreatic Neoplasms	367
Carcinoma, Pancreatic Ductal	77
Path 2
Term	Annotations
Diseases	25889
Neoplasms	4705
Neoplasms by Histologic Type	1613
Neoplasms, Glandular and Epithelial	1049
Carcinoma	868
Adenocarcinoma	612
Carcinoma, Ductal	102
Carcinoma, Pancreatic Ductal	77